Xavier Charmetant

6PUBLICATIONS
31CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 26, 2026
Chronic Kidney Disease-Associated Defect in Humoral Immune Response Is Driven by Inflammation.

Maxime Espi, Xavier Charmetant, Floriane Fusil

|Sep 21, 2022
Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation.

Xavier Charmetant, Chien-Chia Chen, Sarah Hamada

|Sep 12, 2022
Hamster organotypic kidney culture model of early-stage SARS-CoV-2 infection highlights a two-step renal susceptibility.

Sophie R Shyfrin, Marion Ferren, Laure Perrin-Cocon

|Feb 03, 2022
Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine.

Xavier Charmetant, Maxime Espi, Thomas Barba

|Feb 01, 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.

Xavier Charmetant, Maxime Espi, Ilies Benotmane

|Feb 22, 2020
A new expression of immune checkpoint inhibitors' renal toxicity: when distal tubular acidosis precedes creatinine elevation.

Xavier Charmetant, Cécile Teuma, Jennifer Lake

Pageof 1